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Insulin resistance and hypertension are considered as prototypical “diseases of civilization” that are manifested in
the modern environment as plentiful food and sedentary life. The human propensity for insulin resistance and
hypertension is a product, at least in part, of our evolutionary history. Adaptation to ancient lifestyle characterized
by a low sodium, low-calorie food supply and physical stress to injury response has driven our evolution to shape
and preserve a thrifty genotype, which is favorite with energy-saving and sodium conservation. As our civilization
evolved, a sedentary lifestyle and sodium- and energy-rich diet, the thrifty genotype is no longer advantageous,
and may be maladaptive to disease phenotype, such as hypertension, obesity and insulin resistance syndrome.
This article reviews human evolution and the impact of the modern environment on hypertension and insulin
resistance.
Keywords: Insulin resistance, Hypertension, Evolution, Inflammation and sodiumBackground
Diminished tissue sensitivity to insulin is a characteris-
tic of various pathological conditions termed the insulin
resistance syndrome, also known as the metabolic syn-
drome or cardiometabolic syndrome [1]. The metabolic
syndrome is not a single disease, but rather a complex
cluster of symptoms that include a large waist circumfer-
ence, hypertension, hyperglycermia, dyslipidemia and in-
sulin resistance, all of which are commonly associated
with increased risk of obesity and Type 2 Diabetes [2].
Since patients with metabolic syndrome are commonly
afflicted with cardiovascular morbidities, the metabolic
syndrome and cardiovascular diseases share common
pathways including increased oxidative stress, defective
glucose, lipid metabolism, low grade inflammation, hy-
percoagulability and endothelial damage. Previously, in-
vestigators proposed to use the “circulatory syndrome”
to refine the metabolic syndrome concept through the
addition of markers of cardiovascular diseases such as
renal impairment, microalbuminuria, arterial stiffness
and left ventricular dysfunction [2]. It has become in-
creasingly obvious that insulin resistance and the efforts* Correspondence: zhoums1963@163.com; yuvascular@163.com
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reproduction in any medium, provided the ormade by the insulin-targeted organs to compensate for
this defect play a vital role in the pathogenesis and cli-
nical course of the metabolic syndrome [3].
Insulin resistance and hypertension are the compo-
nents of metabolic syndrome and often coexist [4]. Clin-
ical studies have shown that about 50% of hypertensive
individuals have hyperinsulinemia or glucose intolerance,
whereas up to 80% of patients with type 2 diabetes have
hypertension [4,5]. In addition to its metabolic effects,
insulin induces vasorelaxation by stimulating the produc-
tion of nitric oxide (NO) in endothelium [6] and regulates
sodium homeostasis by enhancing sodium reabsorption in
the kidney [7,8]; thereby, contributing to the regulation of
blood pressure. Recent studies have demonstrated that
insulin resistance can develop not only in the classic
insulin-responsive tissues, but also in cardiovascular tis-
sues where insulin participates in the development of
cardiovascular diseases and hypertension [1,9]. Insulin
resistance has gained a bad name and is perceived as
deleterious: commonly associated with the metabolic syn-
drome and hypertension that confer an increased risk for
type 2 diabetes and cardiovascular diseases [9]. However,
in human evolutionary history, insulin resistance may be
an essential part of normal homeostasis to facilitate redir-
ection of nutrients to pivotal organs and a physiological
adaptive mechanism to promote our ancestor’s survival intd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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trauma and stress [10,11]. The same mechanism may
be inappropriately activated on a chronic basis on the
current obesogenic environment, leading to the mani-
festation of hypertension, insulin resistance or metabolic
syndrome [12]. This article reviews human evolution and
the impact of modern environment on hypertension and
insulin resistance.
Insulin resistance and elevation of blood pressure as an
adaptive mechanism to promote human survival
Human survival has relied upon the ability to withstand
starvation through energy storage, the capacity to fight
off infection by an immune response, and the ability to
cope with physical stresses by an adaptive stress res-
ponse [11]. The physiological adaptation that is induced
by the fasting state includes increased lipolysis, lipid oxi-
dation, ketone body synthesis, endogenous glucose pro-
duction and uptake and decreased glucose oxidation [13].
These processes are crucial for survival and serve to pro-
tect the organism from excessive loss of protein mass.
Humans are extremely sensitive to glucose deficits, due to
the large energy requirement (glucose) of the brain [11].
The requirement for energy storage is essentially served
by the anabolic actions of insulin, during starvation or in-
fection/inflammation it becomes insulin resistant, along
with many other adaptations [12]. The way to maintain
glucose levels during starvation, pregnancy and infection/
inflammation is through insulin resistance in insulin-
dependent tissues [12,14].
Insulin is an anabolic hormone that plays an important
role in the regulation of glucose, lipid homeostasis and
energy storage through its metabolic effects on classic
insulin-responsive tissues [1]. Specifically, insulin pro-
motes the storage of glucose as glycogen in liver and
skeletal muscles, and facilitates deposition of fatty acids
in the form of triglycerides in adipose tissue [13]. During
insulin resistance, insulin-mediated anabolic metabolic
effects are inhibited in the classic insulin-responsive tis-
sues. For example, adipose tissue and skeletal muscle re-
duce the uptake of glucose and storage of glucose as
glycogen and triglycerides. Concommintently, there is an
increase in the hydrolysis of stored triglycerides and
their mobilization as free fatty acids and glycerol, in which
the liver increases glucose production via gluconeogenesis
and inhibition of glycogen synthesis and storage. Insulin
resistance promotes reallocation of energy-rich substrates
(glucose to the brain, fetus and immune system; fat
to the fetus and the organs) and the compensatory hyper-
insulinemia [13]. Therefore, negative regulation of insulin
signaling could be viewed as a physiologic ‘adaptive me-
chanism” that is activated in certain conditions such as
fasting, inflammation, stress and pregnancy. However, its
persistence at a chronic state is the basis of the ultimatechanges that we recognize as the symptoms of the meta-
bolic syndrome [11].
Insulin has complex vascular actions that appear as
either vascular protective or deleterious effects [1]. Vas-
cular protective effects of insulin, including induction of
vasorelaxation, inhibition of vascular smooth muscle cell
(VSMC) proliferation and anti-inflammation, are media-
ted by stimulating nitric oxide-dependent (NO) mecha-
nisms in the endothelium [1]. Vascular deleterious effects
of insulin include induction of vasoconstriction, VSMC
proliferation and proinflammatory activity. These vascular
effects are mediated through the mitogen-activated pro-
tein kinase (MAPK) pathway [1]. In addition, insulin in-
creases sodium reabsorption in the kidney and promotes
sympathetic nerve activity [8]. Insulin can be both inflam-
matory and anti-inflammatory [1,15], in physiological
condition insulin stimulates endothelial NO production
to exert a vasorelaxation and anti-inflammatory effect.
Whereas, in the state of insulin resistance, the insulin-
stimulated NO pathway is selectively impaired and the
compensatory hyperinsulinemia may activate MAPK path-
way, resulting in enhancement of vasoconstriction, pro-
inflammation, increased sodium and water retention and
the elevation of blood pressure [15,16]. The increased
blood pressure by insulin resistance may contribute to in-
creased blood perfusion to the brain during starvation and
infection, and to the fetus during pregnancy.
Insulin resistance and hypertension are associated with
an unhealthy lifestyle and a systemic low grade
inflammation
Insulin resistance and hypertension are considered to be
Western diseases. It has become clear that most, if not
all, typically Western chronic diseases find their primary
causes in unhealthy lifestyles and that systemic low grade
inflammation is a common denominator [11,17,18]. Our
ancestors (primitive humans) had to undertake conside-
rable physical activity to gain food and had to adapt to
prolonged period of famine [17], which favored fat stor-
age, a trail inherited by modern man. Moreover, our mod-
ern lifestyle, characterized by energy- and sodium-rich
Western diet, sedentary life and high psychosocial stress,
favors positive energy balance. In the long term, this posi-
tive energy balance creates the need for surplus fat storage
[18]. When the capacity for safe lipid storage in adipose
tissue is exceeded lipids overflow to non-adipose tissue,
increasing the risk for chronic systemic low grade inflam-
mation and subsequent insulin resistance, hypertension
and metabolic syndrome [19].
Obesity in humans may be considered as a symptom
of energy imbalance: caloric intake exceeds energy ex-
penditure [11]. The human organism has extensive fuel
reserves in the adipose tissue, which may meet energy
demands for substantial periods. The adipocyte is thought
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cerides and an endocrine organ to secret many hormonal
factors, including lipid mediators, stress kinases and pro-
inflammatory cytokines and chemokines [11]. These mol-
ecules participate in regulating energy metabolism, lipid
storage, and inflammatory responses. In addition, excess
nutrient intake can induce oxidative stress in the adipose
tissue [20]. Oxidative stress conversely exerts significant
effects on adipose tissue biology and can lead to dysregu-
lation of adipocyte function, which manifests as inhibited
adipocyte differentiation, enhanced immune cell infiltra-
tion into adipocytes and increased inflammatory cytokine
secretion [21].
Obesity-induced inflammation is associated with in-
creased adipose tissue macrophage (ATM) infiltration
[22,23]. Similar to a pathogenic response to an invading
bacterium, excess nutrients found in the obese adipose
microenvironment can lead to the pro-inflammatory ac-
tivation and phenotypic switch (from M2 resident to M1
inflammatory macrophage) of macrophage [24]. One of
emerging feature of obesity-associated ATM infiltration
is the linkage of the induction of a chronic inflammation
in white adipose tissue (WAT) that eventually becomes
systemic [22]. Excess WAT is an overactive endocrine
organ secreting an array of inflammatory adipokines,
such as tumor necrosis factor (TNFα), monocyte at-
tractant protein 1 and interleukin 6(IL6) [24]. These in-
flammatory cytokines can not only induce a chronic
inflammatory process in adipocyte tissue, but also be re-
leased into circulatory blood, inhibiting insulin signaling;
resulting in global insulin resistance [25]. Therefore,
chronic inflammation in obesity plays a critical role in
pathogenesis of insulin resistance [26]. Ironically, the for-
mation of a systemic and/or local tissue-specific insulin
resistance due to inflammatory cell activation may actually
be a protective mechanisms that co-evolved with the re-
partition of energy sources within the body during times
of stress and infection [12].
Hypertension is also associated with increased sys-
temic and vascular inflammatory responses and oxida-
tive stress, which may contribute to vascular dysfunction
[4,16]. Although the genetic causes of essential hyperten-
sion remain elusive, studies in Dahl salt-sensitive (DS)
rat, a paradigm of salt-sensitive hypertension in human,
have suggested that chromosome 2 contains quantitative
trait loci for blood pressure and genes encoding inflam-
matory mediators with biological effects on T lympho-
cytes [27]. DS rats exhibit elevation of blood pressure,
vascular inflammation, oxidative stress and endothelial
dysfunction. These symptoms are reduced in the SSBN2
rat, a consomic rat, in which chromosome 2 of the DS rat
is replaced by that of the normotensive Brown Norway rat
[27]. Studies [16,28] in DS rats have shown that oxi-
dative stress and activated oxdative stress-associatedinflammation are linked not only to elevation of blood
pressure and vascular dysfunction but also to insulin re-
sistance, Moreover, antioxidant treatment and inhibition
of the nuclear factor κB inflammatory pathway in DS rats
reduced blood pressure, vascular inflammation, and im-
proved endothelial function, as well as, systemic and vas-
cular insulin resistance. These studies support the notion
that inflammation is a link between hypertension and in-
sulin resistance [26].
Link between insulin resistance and hypertension: what is
the evidence from evolutionary biology?
Evolution by natural selection is a central organizing
concept in biology. For millions of years, living creatures
from lower-level organisms to human beings have been
faced with survival stresses, including famine and infec-
tion [11]. The survival of multicellular organisms de-
pends on the organism’s ability to store energy for times
of low nutrient availability or high energy needs, and the
ability to fight infections [29]. To meet the challenges of
infection and other environmental stress, an activated
immune system has an urgent need for energy-rich sub-
strates that must be allocated from internal and external
energy stores (glycogen, proteins, triglycerides, or free
fatty acids) [30]. An activated immune system usually re-
quires substantial energy in a quiescent state. This re-
quirement rises into an active phase of inflammation
[30]. Therefore, the metabolic and immune systems are
among the most basic requirements across the animal
kingdom [19,31]. It is not surprising then that metabolic
and immune pathways have evolved to be closely linked
and interdependent and that the genes controlling meta-
bolic and pathogen-sensing systems have been highly
conserved from lower-level organisms to mammals [32].
In recent years, new insights have been gained through
multiple interactions between metabolic and immune
system [19,32]. An increasing body of evidence suggests
that energy metabolism is crucial for the maintenance
of chronic inflammation, not only in terms of energy
supply, but also in the control of the immune response
through metabolic signals [11,33]. It is now apparent that
critical proteins are necessary for regulating energy me-
tabolism, such as peroxisome proliferator-activated recep-
tors (PPAR γ), Toll-like receptors, and fatty acid-binding
proteins. These critical proteins also act as links between
nutrients metabolism and inflammatory pathway acti-
vation in immune cells [34,35]. For example, PPAR-γ
a master regulator of adipocyte differentiation, is also
a major molecule that drives the accumulation and
phenotype of Treg cells in adipose tissue [34]; and lep-
tin, an important adipocyte-derived hormone to regu-
late energy homeostasis, can affect thymic homeostasis
and the secretion of acute-phase reactants such as IL-1
and TNF α [36].
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tabolic and immune systems is fundamental for the
maintenance of good health. The basic inflammatory re-
sponse favors a catabolic state and inhibits anabolic
pathways, such as the highly conserved insulin signaling
pathway, resulting in insulin resistance [37]. As a result
of insulin resistance, plasma levels of glucose are ele-
vated to provide energy sources, maintain the function
of vital organs, such as, the heart, brain, and immune
cells, and combat infection. As the heart, brain and leu-
kocytes are considered as insulin insensitive tissues [14],
their energy metabolism is acutely dependent on plasma
levels of glucose [18]. Therefore, insulin resistance result-
ing from acute inflammatory episodes may favor nutrient
poor organisms to fight against infection. However, since
most aspects in a living body occur with constraints on
energy availability, regulation of energy storage and pro-
visions occupy a very high position in the hierarchy of
homeosotatic neuroendocrine immune control [38]. En-
ergy regulation operates not only in the cell, but also in
coordinating centers of the brain, and in endocrine organs
that integrate organismal functions [37].
The time frame of an organism’s response to the acute
inflammatory episode may reflect an adaptive natural se-
lection mechanism for the coordination of the immune
and energy system to fight against infection [39,40]. An
acute infectious disease can be self-limiting, and may
involve an innate immune response of 2-3 days; the
subsequent phase of the adaptive immune response can
last approximately 3 to 4 weeks [40]. Not only does the
infection-induced impairment in health and the related
anorexia exacerbate a significant reduction in intake of
energy-rich substrates but an acute infectious disease
can also be very energy consuming. Therefore, organ-
isms must obtain the fuel from energy storage tissues,
which primarily occur in fat tissue and skeletal muscle
[11,41]. However, an increase of inflammatory cytokines
released from infectious tissue into circulatory blood
may result in fat and muscle insulin resistance to reduce
energy consumption in these tissues, Additionally, a
compensated hyperinsulinemia, high glucose and hyper-
lipidemia favor the body against infection [11]. While
the energy from muscle and fat tissues usually last 3-5
weeks, perfectly matching an adaptive immune response
to combat the infection [42]. Unfortunately, if an adap-
tive immune system cannot appropriately react within
this time frame, the affected individual may die from en-
ergy exhausted [30].
With the exception of an energy requirement, acute
inflammation is often accompanied by local and syste-
mic water loss. Water loss includes local water loss from
the exposed surface area of inflamed tissue as well as
systemic water loss from insensible perspiration through
skin and respiratory tract, and more metabolic water forhigher metabolic reaction [40]. To overcome a systemic
water loss during acute inflammatory episodes, a water
retention system must be activated [40]. The reactive
mechanism for water retention includes activation of
sympathetic nervous system which subsequently results
in activation of renin-angiotensin-aldosterone system,
and activation of hypothalamic-pituitary-adrenal (HPA)
axis with adrenocorticotropic hormone (ACTH), aldos-
terone and cortisol [40]. Interestingly, some hormones
that mediate water retention such as angiotensin II and
aldosterone are also endowed with proinflammatory ef-
fects [43], and has an important role in the pathogenesis
of hypertensive and metabolic diseases [9].
The water retention system shows important similar-
ities with the energy provision system. The operation of
these two interacting systems were likely subject to posi-
tive selection and co-evolved to overcome serious and
transient inflammatory episodes [40]. Induction of en-
ergy storage system and water retention system provides
a survival mechanism in response to acute inflammatory
episodes. However, prolonged operation of these adaptive
programs such as in chronic inflammatory process, which
are currently observed in many cardiovascular, hyperten-
sive and metabolic diseases, can become pathogenic be-
cause there is no program to counteract continuous water
retention and energy appeal actions [10,11].
Is sodium another link between hypertension and insulin
resistance?
Essential hypertension can be classified as salt-sensitive
and salt-resistant, according to the blood pressure res-
ponse to salt loading. Animal and clinical studies suggest
that insulin resistance and hypertension are associated
with salt-sensitivity [44,45]. High salt diet impairs insulin
sensitivity in hypertensive patients with salt-sensitivity but
not in those with salt-resistance [5]. There is a strong clus-
tering of markers of endothelial damage in persons predis-
posed to salt-sensitive hypertension who concomitantly
have insulin resistance and microalbuminuria [45].
Salt sensitivity of blood pressure is an independent risk
factor for development of cardiovascular morbidity and
mortality [5]. The essential hypertensive patients with
salt sensitivity are more insulin resistant than those with
salt-resistance. Furthermore, high salt diet impairs in-
sulin sensitivity only in hypertensive patients with salt-
sensitivity but not in those with salt-resistance, suggesting
that there is a pathogenetic link among hypertension, salt-
sensitivity and insulin resistance [4,28]. A recent clinical
study has shown that insulin resistance enhances the
blood pressure response to sodium intake21. Therefore, re-
duction in sodium intake may be an especially important
component in reducing blood pressure in patients with
multiple risk factors for insulin resistance and the meta-
bolic syndrome [46].
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at least in part, of our evolutionary history [47]. The
evolution of hypertension susceptibility has been hypo-
thesized to begin in Africa. With the hot and humid
climate, effective heat dissipation is essential in hot envi-
ronments and is achieved most efficiently through evap-
orative heat loss [47]. However, sweating due to the hot
climate and excessive labor activities can lead to a large
loss in the amount of salt and water, and eventually lead
to hypovolemia, a threat to human survival. In addition,
human and nonhuman primates living in ancient times
had very low salt intake available. Low salt intake and
large salt losses due to sweating had created robust salt
appetite and renal sodium conservation, which were es-
sential to survival. The principle of natural selection may
have allowed the ancestral sodium-conserving genotype
(thrifty) to persist [48], which may be maladaptive to
the modern environment of sodium abundance, resul-
ting in hypertension. An analogous evolutionary frame-
work, sometimes referred to as the sodium-retention
hypothesis, was proposed to explain the increased preva-
lence of essential hypertension in some ethnic groups.
Briefly, ancient human populations living in hot, hu-
mid areas adapted to the environment by retaining salt.
Whereas populations in cooler, temperate climates adap-
ted to conditions of higher sodium levels [47,48]. Experi-
mental evidence from trials of dietary sodium restriction
generally supports the hypothesis of a sodium-hyperten-
sion link, particularly among salt-sensitive populations
[49]. In support of this hypothesis, a study recently found
that African Americans have a higher prevalence of salt
sensitivity than White Americans [50].
Evidence suggests that genetic susceptibility to hyper-
tension is ancestral [47]. Ancestral alleles increase the
risk of hypertension and the derived protective alleles ap-
pear to carry the signature of positive selection at tightly
linked neutral sites. For example, chimpanzees and hu-
mans share hypertension susceptibility alleles in at least
two genes: angiotensinogen (AGT) and the epithelial so-
dium channel γ subunit (ENaCγ), genes involved in the
regulation of sodium and blood pressure homeostasis
[39]. AGT carries two variants: a promoter A-6G variant
and the T235M variant, which are associated with hy-
pertension [40]. Human genomic studies suggest that the
genetic origins of susceptibility to common chronic dis-
ease are due to adaptations to ancestral environments
[47], these alleles improved survival in ancestral environ-
ments characterized by salt scarcity, low-calories diets,
and regular physical activity [39]. In the current environ-
ment of salt and caloric excesses and infrequent physical
activity, these alleles can be detrimental, leading to obesity,
type 2 diabetes and hypertension [48].
In salt-sensitive hypertension, the accumulation of so-
dium in tissue has been presumed to be accompanied bya commensurate retention of water to maintain the iso-
tonicity of body fluids. Recent studies [51,52] suggest
that immune cells, such as mononuclear phagocyte system
and macrophages, are responsible for interstitial hyper-
tonic sodium retention, resulting from high salt diet in-
take, and stimulate lymphcapillary network formation via
production/release of tonicity-responsive enhancer bind-
ing protein and vascular endothelial growth factor C. Not-
ably, vascular endothelial growth factor C may serve as an
extra sodium and water storage in skin to buffer extra-
cellular volume expansion and maintain blood pressure
homeostasis [51]. Deletion of the mononuclear phagocyte
system or inhibiting the interaction of VEGF-C with
its receptors (VEGF receptor 3 and/or VEGF receptor
2) blocked the regulatory response of mononuclear pha-
gocyte system to interstitial sodium accumulation and
augmented salt-induced hypertension, suggesting that im-
mune system plays the role in the regulation of sodium
and water homeostasis.
Interestingly, insulin has been shown to inhibit sodium
excretion by increasing sodium reabsorption in the kid-
ney [8]. It is well known that sodium is the main deter-
minant of body fluid distribution. Sodium accumulation
causes water retention and often, high blood pressure.
Sodium transport through various nephron segments, is
quite important in regulating sodium reabsorption and
blood pressure [8]. ENaC and sodium proton exchanger
type 3 (NHE3) are main mediators to regulate sodium
reabsorption in renal tubules. It has been shown that in-
sulin can regulate ENaC and NHE3, therefore increasing
renal tubular sodium reabsorption [8,53]. As mentioned
earlier, like energy storage, insulin-mediated sodium pre-
servation may be an adoptive mechanism for human
survival during ancient time [7,54].
Thrifty hypothesis
Natural selection shapes organisms in functioning within
a particular set of environmental conditions [55]. Be-
cause organisms adapt to the totality of their environ-
ment, or ecological niche, it is hypothetically possible
that natural selection favors organisms harboring the
genotype for a metabolic system (such as the insulin sig-
naling pathway) that has an increased response to in-
flammation [48]. Since regulation of energy storage and
metabolism and the preservation of body fluids are cri-
tical for organism’s fight against famine, infection and
physical stress, it has also been hypothesized that genes
responsible for energy regulation and sodium preserva-
tion have been positively selected [48]. These genes were
termed thrifty genes. The notion of thrifty genotype was
initially proposed by Neel [56], in which he argued that
certain genotypes were selected into the human genome
because of their selective advantage over the less thrifty
genes. Neel [56] defined a thrifty genotype as “being
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food”. In ancient time, food supply was never consistent.
Thus, it is contended that the ancient hunter-gatherer had
cycles of feast and famine, punctuated with obligate
periods of famine, and certain genes evolved to regu-
late efficient intake and utilization of fuel stores [14,56].
Subsequently, during famines, individuals with the thrifty
genotype would have a survival advantage because they
relied on larger, previously stored energy to maintain ho-
meostasis [14]. Based on Neel’s thrifty genotype hypo-
thesis, it is proposed that a genetic predisposition in
developing diabetes was adaptive to the feast and famine
cycles of Paleolithic human existence, allowing humans to
fatten rapidly and profoundly during times of feast so that
they may have a higher chance of survival during times of
famine [55,56]. This would have been advantageous back
then, but not in our current environment, as the current
environment provides ready abundant energy rich food.
Thus, the preserved thrifty genes that co-regulate energy
storage and immune system may actually promote the de-
velopment of obesity or type 2 diabetic mellitus [55].Ancient  human 
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adiposity [14]. Recent studies emphasize that adiposity,
like stature, is a polygenic trait, and that population gen-
etic variability primarily comprises different frequencies
of particular alleles, rather than major systematic dif-
ferences [14,60]. Ethnic differences in body composition,
representing different load-capacity ratios, may contri-
bute to ethnic variability in metabolic risk. Lower lean
mass and greater adiposity each indicate thrift. It has
been proposed that body composition phenotypes, in-
cluding the fat-lean ratio, the organ-muscle ratio, the
central –peripheral ratio and the expandability of adi-
pose tissue, are relevant to variability in the metabolic
syndrome [60].
Conclusions
Abundant clinical and epidemiologic evidences demon-
strate a close linkage between insulin resistance and
hypertension. The coexistence of insulin resistance and
hypertension results in a substantial increase in the risk
of developing cardiovascular disease and type II diabetes
[5]. Underlying the mechanisms is complex and may in-
volve a low grade chronic inflammation and oxidative
stress. As humans evolve, the thrifty genotype for high
cytokine responder (eradication of injury), mild insulin
resistance (protection against starvation), or sodium pre-
servation (maintenance of body fluid),which favored our
ancestors, aiding them in the survival of critical conditions
such as famine, infection, trauma and physical stressors,
may be positively selected, which may be maladaptive to
our current, modern lifestyle, resulting in insulin resis-
tance, hypertension, type II diabetes and cardiovascular
diseases (Figure 1) [12,61].
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